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Video-assisted endoscopic techniques have reduced operative trauma in adult 
thoracic and general surgery, but applications in chiidren with congenital heart 
disease have been limited. We report the development of video-assisted thoracic 
surgery procedures for neonates and infants with cardiovascular disease. Endo- 
scopic instruments and techniques for pediatric cardiovascular p ocedures were 
designed and tested in the animal laboratory. Forty-eight operations were subse- 
quently performed in 46 pediatric patients ranging in age from 2 hours to 14 years 
(median 9 months), weighing from 575 grams to 54 kg (median 8.5 kg). Clinical 
applications included seven different surgical procedures: patent ductus arteriosus 
interruption i infants (n = 26) and premature neonates (n = 5), vascular ring division 
(n = 8), pericardial drainage and resection (n = 3), arterial and venous collateral 
interruption (  = 2), thoracic duct ligation (n = 2), epicardial pacemaker lead insertion 
(n = 1), and diagnostic thoracoscopy (n = 1). There was no operative mortality. 
Technical success, defined as a video-assisted procedure completed without incising 
chest wall musde or spreading the ribs, was achieved in 39 of 48 procedures (82%), with 
thoracotomy required to complete nine procedures. Most patients (22/25, 88%) under- 
going elective ductus ligation were extubated inthe operating room and discharged from 
the hospital within 48 hours of the operation. Eight of the last 10 patients having ductus 
ligation were discharged on the first postoperative day. Residual dnctal flow was 
assessed by (1) transesophageal chocardiography in the operating room (incidence: 
0/25, 0%, 70% CL 0% to 7.3%); (2) discharge auscultation (incidence: 1/30, %, 70% CL 
0.5% to 10.8%); and (3) follow-up Doppler echocardiography (incidence: 3/25, 12%, 70% 
CL 5.4% to 22.6%). Video-assisted horacoscopic techniques can be safely applied to 
pediatric patients with patent ductus arteriosus and vascular rings and may become an 
effective addition to the staged management of more complex forms of congenital heart 
disease. (J THORAC CARDIOVASC SURG 1995;109:499-508) 
Redmond P. Burke, MD (by invitation), Gil Wernovsky, MD (by invitation), 
Mary van der Velde, MD (by invitation), Dolly Hansen, MD (by invitation), and 
Aldo R. Castaneda, MD, Boston, Mass. 
B y reducing surgical trauma while enhancing visu- alization, video-assisted endoscopic techniques 
have assumed an increasing role in operations on 
adults. 1 The demands for improved visualization 
and reduced tissue trauma are also compelling in 
the pediatric population, where size constraints are 
extreme and immature tissues are vulnerable to 
mechanical injury. Pediatric video-assisted thoracic 
surgery (VATS) applications have been limited by a 
lack of equipment and techniques adapted to small 
patients. Pediatric VATS has been reported for 
patent ductus arteriosus (PDA) interruption 2 and 
vascular ing division, 3which have been performed 
successfully, with minimal morbidity. So that the 
applications of pediatric VATS could be extended, 
endoscopic instrumentation a d surgical strategies 
were developed to accommodate he small size and 
complex cardiopulmonary physiology characteristic 
of this patient population. This report reviews our 
initial experience with VATS in the animal abora- 
tory and subsequently in 46 patients with congenital 
heart disease. 
Methods 
Animal experience 
Subjects. Pediatric cardiovascular VATS applications 
were developed in the animal laboratory, newborn York- 
shire swine heilig used to approximate the size and 
anatomic relationships in the human neonatal pleural 
space. Animals were treated humanely according to 
guidelines established by the National Society for Medical 
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Table I. Pediatric VA TS instruments for cardiovascular procedures 
Useful weight Cost (1993 
Instrument Trocar size range Company* dollars) 
Videoscope 2.7 mm 2.8 mm Under 2 kg Dyonics 2,785 
Videoscope 4mm 4 mm Under 40 kg Dyonics 2,785 
Camera Under 40 kg Dyonics 22,500 
Monitor All Dyonics 9,800 
Lung retractor 5 mm Over 5 kg Advanced Surgical 595 
Lung retractor 4 mm Under 5 kg Pilling Prototype 
Grasper 2.5 mm Under 20 kg Dyonics 1,500 
Cautery probe 4 mm All , Pilling 40 
Clip applier Over 5 kg Weck 390 
Clip applier All Pilling Prototype 
Needle holder 4 mm All Pilling Prototype 
Scissors 4 mm Under 40 kg Dyonics 750 
Trocar 2.8 and 4 mm Under 40 kg Pilling 250 
Vascular clamp 4 mm Under 40 kg Pilling Development 
Angled grasper 4 mm Under 40 kg Pilling Development 
*Advanced Surgical, Advanced Surgical, Inc., Princeton, New Jersey; Dyonics, Smith and Nephew, Dyonics, Inc., Andover, Massachusetts; Pilling, Pilling Co., 
Fort Washington, Pennsylvania. 
Research and the "Guide for the Care and Use of 
Laboratory Animals" prepared by the Institute of Labo- 
ratory Animal Resources and published by the National 
Institutes of Health (NIH Publication No. 86-23, revised 
1985). The protocol was reviewed and approved by the 
Animal Care and Use Committee, Children's Hospital, 
Boston, Massachusetts. 
Anesthesia. Anesthesia was induced with ketamine 40 
mg/kg, given intramuscularly, and maintained with a mix- 
ture of halothane (0.5% to 1%) and oxygen. Animals' 
lungs were ventilated at 15 ml/kg with a volume-cycled 
ventilator at 10 to 20 breaths/min. Arterial pressure and 
continuous electrocardiographic tracings were monitored. 
Animals recovered in the animal facility and were put to 
death with ketamine (100 mg/kg) on postoperative day 1 
for inspection of the operative sites. 
Basic surgical technique and instruments. Each animal 
underwent PDA interruption and pericardial resection. 
Procedures were planned to assess technique and instru- 
ment performance in four areas: access, exposure, dissec- 
tion, and hemostasis. Data recorded included procedure 
times, operative mortality, morbidity, postmortem dissec- 
tion results, and subjective assessment of instrument perfor- 
mance. Current VATS instruments are listed in Table I. 
Four thoracostomies were used in each procedure. 
Whenever possible, so that intercostal trauma could be 
minimized, instrument diameters were reduced to 4 mm 
or less for animals over 2 kg and 2.8 mm or less for those 
under 2 kg. Arthroscopic videoscopes with a 7 cm working 
length, 2.7 or 4 mm diameters, and a 30-degree face angle 
were coupled with cameras providing 4× magnification. 
Trocars allowed rapid instrument exchange, and a combi- 
nation of short (1.5 cm) and long (4 cm) trocars with 2.7 
or 4 mm internal diameters accommodated a wide fange 
of chest wall thicknesses. Chest wall muscles were never 
incised or divided; instead, trocar placement was achieved 
with blunt dissection with the aid of a curved hemostat. 
This technique also prevented pleural tent formation, 
chest wall bleeding, and lung injury. Temporary hypoven- 
tilation allowed safe videoscope insertion. 
Thoracostomy positions for each procedure were pat- 
terned to maximize exposure and minimize instrument 
contact. Single lung ventilation techniques were lirnited by 
tracheal size, necessitating retraction of the inflated, mov- 
ing lung. Initial efforts to retract he lung with malleable 
coronary probes resulted in poor exposure and pulmonary 
parenchymal trauma. Expandable retractors, with broad 
surface areas, maintained their position despite underly- 
ing lung motion, and were atraumatic. 
For precision, a two-handed issection technique was 
adopted. Two separate ports were used to admit a 2.5 mm 
diameter grasper and a cautery probe. The lack of depth 
perception during VATS and the attendant risk of injury 
to underlying structures were accommodated by a modi- 
fied dissection technique with an L-shaped electrocautery 
probe, which was used to elevate tissues away from 
underlying structures before the current was activated. 
When necessary, countertraction was achieved with stay 
sutures brought in through the chest wall. 
Even small amounts of blood in the operative field 
significantly reduced visualization, so that cautery dissec- 
tion was essential. PDA occlusion was accomplished with 
single vascular clips. Clip appliers designed for adult 
VATS were effective in animals over 3 kg, but instrument 
diameters were too large for the intercostal space in 
animals under 2 kg. Prototype clip appliers were tapered 
to minimize thoracostomy size and maintain tactile con- 
trol of the closure force. This tapering was balanced 
against the need to supply sufficient force to achieve 
complete clip closure. Suction was used sparingly because 
it reinflated the lung and compromised exposure. 
Clinical experienee 
Patients. All patients referred for pediatric cardiovas- 
cular VATS procedures to Children's Hospital, Boston, 
were included in this report, with no exclusions based on 
age, size, or degree of cardiopulmonary d sfunction. The 
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only general exclusion criterion for VATS was extensive 
pleural adhesions. For VATS PDA interruption, specific 
exclusion criteria included patients with calcified ducts (by 
chest roentgenograms), PDAs equal in diameter to the 
descending aorta, and those with transcatheter occlusion 
devices within the ductal lumen. During this study, all 
patients referred for surgical PDA closure underwent 
VATS, except in six cases in which open procedures were 
performed because of patient preference or unavailability 
of the VATS surgeon. For VATS vascular ing division, 
patients with rings composed entirely of patent vascular 
structures were excluded, as were patients with an aortic 
diverticulum compressing the airway. 
Patient charts, operative reports, and intraoperative 
video recordings were retrospectively reviewed. Baseline 
clinical data included age and weight at operation, preop- 
erative cardiac anatomy and prior cardiac surgical proce- 
dures, total operative time (defined as the time from 
entering to leaving the operating room), procedure time 
(defined as the time from incision to closure), intraoper- 
ative arterial oxygen saturation and end-tidal carbon 
dioxide, intraoperative transesophageal chocardiography 
results, need for transfusion, duration of mechanical 
ventilation (the time from arrival in the intensive care unit 
until extubation), complications, hospital stay, echocardi- 
ography, and chest x-ray results. Procedures that necessi- 
tated a thoracotomy (defined as any incision in chest wall 
muscle or rib spreading with a retractor) to complete the 
operation were considered technical failures, but not 
complications, if the operation was completed success- 
fully. Follow-up telephone interviews were conducted, 
and resnlts of postoperative examinations by referring 
physicians were obtained. Patients who had had PDA 
closure underwent follow-up echocardiography from 1 to 
6 months after the operation. 
Anesthesia. Each patient was assessed before the oper- 
ation for airway size and anatomy. Patients deemed 
suitable for one-lung ventilation (more than 8 years of age 
and 25 kg in weight) were intubated with one of several 
techniques, including double-lumen endotracheal tube, 
selective left or right main-stem bronchus intubation with 
fiberoptic guidanee, or standard endotracheal intubation. 
Routine monitoring included echocardiography, end-tidal 
carbon dioxide, transcutaneous oximetry, and blood pres- 
sure by automated cuff. Arterial lines were placed selec- 
tively. All patients were given general anesthesia. Those 
with cardiopulmonary d sfunction were anesthetized with 
a narcotic-relaxant technique (fentanyl/pancuronium), 
and those with minor lesions received inhalational anes- 
thetic agents (halothane or isoflurane) and a muscle 
relaxant. 
Basie surgieal teehnique and instruments 
PDA occlusion. Patients were placed in a right lateral 
decubitus position and four thoracostomies were made, 
each corresponding  size to the appropriate instrument 
for that position (from 2.7 mm for the grasper and 
videoscope to 7 mm for the large clip applier). The 2.7 mm 
diameter videoscope was used in all neonates weighing 
less than 2 kg (n = 4), and the 4 mm videoscope was used 
for those weighing more than 2 kg (n = 27). The left upper 
lobe was retracted inferomedially. Transient hypoxia nd 
hypercarbia were corrected by repositioning the retractor 
and reinflating atelectatic lung segments. The parietal 
pleura overlying the duct was elevated with the grasping 
forceps, and the cautery dissector was used to incise the 
pleura and develop a flap. The upper and lower duct 
angles were dissected without skeletonizing the duct, and 
the recurrent nerve was swept medially. When the upper 
and lower borders were free, the appropriately sized 
vascular clip was advanced through the posterior thora- 
costomy (not through a trocar) and placed around the 
duct, parallel to the aorta. Clip size was chosen to 
completely encircle the duct, to avoid impaling the wall. 
Preparations for volume infusion and thoracotomy were 
made before clip closure. 
Real-time transesophageal echocardiography (TEE) 
was used to confirm complete interruption of ductal flow 
as the clips were applied. The aorta nd left pulmonary 
artery were also examined by TEE before leaving the 
operating room in each case. Persistent ductal flow by 
TEE prompted placement of a second clip. If this was 
unsuccessful, a thoracotomy incision was made by con- 
necting the two posterior thoracostomies, and the ductus 
was divided with an open technique. Single 12F thoracos- 
tomy tubes were positioned apically under direct vision. 
Vascular ring division. Anesthesia, positioning, trocar 
placement, and exposure were as described for PDA 
interruption. Patients with respiratory symptoms under- 
went intraoperative bronchoscopy to localize the airway 
compression and rule out the presence of complete tra- 
cheal rings (which would mandate an open approach with 
cardiopulmonary b pass). With the subclavian artery used 
to orient dissection, the vascular ring elements were 
identified, freed from the underlying esophagus, and 
divided between vascular clips. Fibrous bands encircling 
the esophagus were lysed with the cautery probe. Pleural 
edges were cauterized to prevent lymphatic leak, and 
single 12F thoracostomy tubes were placed. 
Additionalprocedures. The instruments and techniques 
developed for VATS PDA occlusion and vascular ing 
division were adapted to several other cardiovascular 
lesions. 
Statistieal methods. Data were reported as median and 
fange and were analyzed by linear regression. By means of 
the exact binomial method, 70% confidence limits were 
given for proportions. An F test was used to compare 
variance between groups. Statistical significance was de- 
fined as p < 0.05. 
Results 
Animal experience. Between January and April 
1993, VATS was performed in 19 animals whose 
ages ranged from 4 to 12 days (median 7 days) and 
weight from 1.35 to 3.48 kg (median 1.85 kg). 
Survivors, 16 of 19 (84%), were extubated within 1 
hour of the operation and were able to walk and 
drink. Postmortem dissection, on the first postoper- 
ative day, demonstrated secure PDA occlusion (by 
probing the lumen) in each animal with no gross 
injury to the heart, lung, or chest wall. Improvement 
in technique and instrument design, as well as 
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Fig. 1. VATS PDA interruption and pericardial window. Results of animal experience showing the 
relationship between procedure number and procedure time (from incision to closure). 
Table II. Results of VA TS PDA interruption 
Elective Premature 
operations infants 
Patients n = 25 n = 5 
Procedures n = 26 n = 5 
Age 2.4 yr (47 days-14 yr) 18 days (16-31 days) 
Weight 11.3 kg (3.6-46 kg) 1140 gm (575-2500 gin) 
Highest ETCO2 42 (31-70) 33 (30-43) 
in OR 
Lowest 02 sat. in 99% (86%-100%) 98% (83%-100%) 
OR 
Postop. stay 2 days (1-8 days) 38 days (24-60 days) 
Complications 1" it 
Mortality 0 0 
Values are expressed as median and range. ETCO» End-tidal carbon 
dioxide; OR, operating room. 
*Bleeding during open division ecessitated transfusion. 
tTransient left recurrent nerve paresis. 
practice with the procedure, resulted in a significant 
reduetion in procedure times (p = 0.01). The rela- 
tionship between procedure time and procedure 
number is depicted in Fig. 1. 
Complications. Three proeedures were eompli- 
cated and the animals were put to death immedi- 
ately: a hemothorax developed uring elip applier 
insertion in one animal, lung trauma resulted from a 
retractor in another, and a pleural tent developed 
during trocar placement in the third, preventing 
videoscope insertion. 
Clinical experience 
PDA interruption. From April 1993 to March 
1994, 30 patients with PDA underwent 31 VATS 
interruptions by one surgeon (R.P.B.). Results are 
summarized in Table II. There were 26 elective 
PDA closures and 5 urgent procedures inpremature 
infants. In the elective PDA closure group, ó of 25 
patients (24%) had symptoms and 6 of 25 (24%) had 
other cardiac lesions, including bicommissural ortic 
valve (n = 2), small ventricular septal defects (n = 
3), and mild left pulmonary artery stenosis (n = 1). 
The premature patients undergoing urgent PDA 
occlusion had a median gestational ge of 27 weeks 
(fange 24 to 36 weeks) and underwent VATS at a 
median age of 18 days (range 16 to 31 days). All 
were in eongestive heart failure and ventilator de- 
pendent, and 3 had multiple organ system failure. 
All had had unsuccessful indomethacin therapy, and 
preoperative serum creatinine values ranged from 
0.4 to 1.4 mg/dl (median 0.9 mg/dl). 
The relationship between total operating room 
times, procedure times, and procedure number for 
all PDA procedures is depicted in Fig. 2. These 
times decreased by an average of 4.8 and 2.3 min- 
utes per operation, respectively (significant at p = 
0.01 andp = 0.03). There was a significant decrease 
in the variability of the operating room times (p = 
0.002) from the first half of the experience to the last 
half, whereas there was no change in the variability 
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Fig. 2. VATS PDA interruption. Results of clinical experience showing the relationship between total 
operating room time (solid line), procedure time (hatched line), and procedure number. 
of the procedure times. There was no significant 
difference in the operating room or procedure times 
between the premature patients and the patients 
having elective procedures. Seven PDA procedures 
(23%) had total operative times of more than 200 
minutes, related to difficult exposure (n = 3), pro- 
longed anesthesia time for single lung techniques 
(n = 3), and mechanical instrument failure (clip 
applier) necessitating thoracotomy (n = 1). 
The incidence of residual ductal patency is pre- 
sented in Table III. The premature infants were too 
small for the TEE probe and were assessed by intra- 
operative transthoracic echocardiography, which 
showed complete PDA interruption in all patients. 
Two patients had residual f ow by intraoperative TEE 
after placement of a single clip, necessitating place- 
ment of a second clip. This was successful in one; 
however, the second patient, described later, had 
persistent flow and required open division. FoUow-up 
echocardiography in the elective PDA group was 
obtained in 25 of 30 patients (83%), from 1 to 12 
months after the operation (median 2months). Three 
patients with no residual flow by intraoperative TEE 
subsequently had träce flow by Doppler interrogation 
at follow-up echocardiography, and one of these pa- 
tients had a soft murmur. 
Most patients having elective PDA interruption 
(81%) were extubated in the operating room. Four 
patients were extubated in the intensive care unit 
Table III. Residual patency after VATS PDA 
interruption 
Residual 70% 
Technique flow Percent CL (%) 
Intraoperative 0/25 0 0-7.3 
Discharge auscultation 1/30 3 0.5-10.8 
Postop. echocardiography 3/25 12 5.4-22.6 
(median 2mo) 
from 2 to 4 hours after the operation. All chest ubes 
were removed on postoperative day 1. Eight of the 
last 10 patients were discharged the day after the 
operation. Follow-up reports from the referring 
physicians were obtained for all patients in the PDA 
group at a median of 1 month after the operation 
(range 1 week to 1 year) and confirmed complete 
wound healing in all patients, with no incisional 
pain. 
COMPLICATIONS. NO deaths occurred in the PDA 
group. Two patients underwent horacotomy to 
complete the PDA procedure. In the first patient 
undergoing VATS PDA interruption, a 2.5 kg pre- 
mature neonate (36 weeks' gestation) with a large 
ductus, the chest was opened intentionally after the 
duct dissection by VATS was completed, to mini- 
mize the risk of the first procedure (which was 
uncomplicated). The eighteenth elective operation, 
on a 9.4-month-old, 5.7 kg boy, was completed 
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Table IV. Results of VATS vascular ing division in 
eight patients 
Anatomy 
Double aortic arch, atretic left n = 3 
arch, LLA 
Right aortic arch, aberrant n = 5 
LSCA, LLA 
Age 4.7 mo (42 days-5.5 yr) 
Weight 6 kg (1.78-17.1 kg) 
Total operating room time 245 min (155-275 min) 
Postop. hospital stay 3 days (3-26 days) 
Symptoms resolved 7/8 (88%) 
Complications 1 (13.5%) 
Mortality 0 
Values are expressed asmedian and range. LLA, left ligamentum arterio- 
sum; LSCA, left subclavian artely. 
without difficulty, and intraoperative TEE showed 
complete ductal interruption. A murmur was heard 
4 hours after the operation, however, and echocar- 
diography confirmed a small residual PDA. Two 
days later, the patient underwent reoperative VATS 
placement of a second PDA clip. As the applier was 
closed, TEE demonstrated interruption of the resid- 
ual ductal flow, but flow returned when the applier 
was released. Because of this mechanical failure, a 
thoracotomy was made, and the duct was divided. 
During open division, bleeding from the duct neces- 
sitated transfusion. The postoperative course was 
complicated by pleuropericardial effusions. The 
child was discharged on postoperative day 8 and was 
doing well at 3-month follow-up. The clip applier 
was thought o have failed as a result of mechanical 
stress and was replaced. 
One premature patient had left-sided vocal cord 
paresis after the operation, documented by laryn- 
goscopy. This child recovered and was discharged. 
There were no wound infections and no pneumo- 
thoraces necessitating tube thoracostomy. 
Vascular ring division. Eight patients underwent 
VATS vaseular ring division. All had symptoms before 
the operation, with airway obstruction alone (n = 2), 
esophageal obstruction alone (n = 3), or both (n = 3). 
Two patients were born prematurely at 27 and 33 
weeks of gestation; the former infant required an 
urgent operation at 42 days after birth for increasing 
airway pressures on mechanical ventilation. Three 
patients had concomitant medical problems, including 
ventricular septal defect (n = 1), laryngomalacia (n = 
1), and chronic renal failure (n = 1). Preoperative 
studies included barium swallow and echocardiogra- 
phy in all patients. Five patients had preoperative 
magnetic resonance imaging. 
Operative results are summarized in Table IV. 
Follow-up interviews and examinations from 1.5 to 
9.5 months (median 5.9 months) after the operation 
demonstrated complete wound healing in all patients 
with symptomatic improvement in seven of eight 
(88%). After VATS vascular ring division, the prema- 
tute infant with increäsing airway pressures had imme- 
diate improvement in respiratory function and was 
extubated 3 days later. One patient with preoperative 
stridor and regurgitation had persistent but less severe 
stridor after division of ä left-sided ligamentum afising 
from an aberrant left subclavian artery and a right 
aortic ärch. Follow-up magnetic resonance imaging 
and bronchoscopy revealed mild right lateral tracheal 
compression above the carina. 
COMPLICATIONS. NO operative deaths occurred in 
the vascular ring group. Three patients required 
limited thoracotomies, connecting the posterior two 
thoracostomies, to divide patent vascular structures 
discovered uring the thoracoscopic dissection (n = 
2) and to control bleeding (n = 1). The latter patient 
had ä right aortic arch with an aberrant leff subcla- 
vian artery. When the ligamentum was divided 
(between vascular clips), bleeding obscured the op- 
erative field. Immediate thoracotomy was per- 
formed, and the hemorrhäge was localized to a small 
adventitial vessel and controlled. No transfusion was 
required and the patient recovered. 
One patient had chylothorax after division of a 
leff ligamentum ärising from an aberrant leff sub- 
clavian artery, which required a second VATS pro- 
cedure to ligate the leaking lymphatic vessel. The 
subsequent recovery was uneventful. 
Additional procedures. Nine VATS procedures 
were performed for diverse cardiovascular lesions 
(Table V). VATS was used in several patients with 
complex congenital heart disease. A 12-year-old 
patient with a single ventricle, who previously had a 
palliative Fontan procedure, presented with increas- 
ing cyanosis. He had an arteriäl oxygen saturätion of 
86% in room air, resulting from a large venous 
collateral diverting blood from the innominate vein 
to the left atrinm. Attempts at tränscatheter occlu- 
sion were unsuccessful and he was referred for 
VATS collateräl interruption, which was performed 
through the leff side of the chest. Within minutes of 
colläteral ligation, the patient's arterial oxygen ten- 
sion increased from 82 to 323 mm Hg (inspired oxygen 
fräction 100%). He was extubated in the operating 
room and discharged the hext morning. At 5-month 
follow-up, the patient had no incisional pain, and the 
transcutaneous oxygen saturation was 98%. 
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Table V. VA TS additional procedures 
Required 
Patient Age Weight  Diagnosis Procedure thoracotomy Complication Stay Outcome 
1 4 days 3.1 kg TOF/PS, AP collat- Collateral inter- Yes None 31 days Discharged, oing 
erals ruption (arteri- well 
al) 
2 12 yr 32 kg Cyanotic after Fon- Collateral inter- No None 2 days Discharged, oing 
tan operation ruption (ve- well 
nous) 
3 6 yr 18 kg Recurrent pneumo- Diagnostic VATS No None 3 days Negative explora- 
nia tion, discharged, 
4 2 hr 1.4 kg Congenial heart Epicardial pace- Yes None 93 days 
block, fetal hy- maker 
drops 
5 36 days 1.8 kg Pericardial etNsion Pericardial drain- No MSOF 37 days 
after repair of age 
aortic arch and 
VSD 
6 17 days 3.2 kg Pericardial effusion Pericardial drain- No None 5 days 
after atrial sep- age 
tectomy/sbunt 
doing weU 
Grew to 2 kg, per- 
manent pacer 
placed, dis- 
charged, doing 
weil 
Died in hospital 
7 12 yr 54 kg Pericarditis, JRA Pericardial resec- Yes None 10 days 
tion 
Discharged, no 
ettusion by echo, 
to return for 
BDCPA/Fontan, 
doing well 
Discharged, no 
effusion by echo, 
doing weil 
8 3.3 yr 16 kg Pericardial ettusion Thoracic duct No Persistent effu- 25 days Discharged, clear 
after TOF repair interruption sion required CXR, doing well 
thoracotomy 
and duct liga- 
tiont 
9 6 yr 17 kg Chylothorax after Lymphatic liga- Yes None 2 days Discharged, clear 
VATS vascular tion CXR, doing weil 
ring division 
AP, Aortopulmonary; BDCPA, bidirectional cavopulmonary nastomosis; CXR, chest x-ray; stay, postoperative hospital stay; MSOF, multisystem organ 
failure; TOF/PS, tetralogy ofFaUot/pulmonary stenosis; VATS, video-assisted horacoscopic surgery; VSD, ventricular septal defect; JRA, Juvenile rheumatoid 
arthritis. 
Four patients in this group required thoracotomy 
to complete their procedures. In two patients this 
was done for safety: improving vascular control 
during division of an aortopulmonary collateral in a 
3.1 kg patient with tetralogy of Fallot and pulmo- 
nary atresia nd facilitating hemostasis during peri- 
cardial resection in a patient with unanticipated 
dense, vascularized pericardial adhesions. In two 
patients instrument limitations led to thoracotomy. 
A 2-hour-old premature neonate weighing 1.4 kg, 
with fetal hydrops as a result of congenital heart 
block, required a small thoracotomy to complete 
placement of an epicardial pacemaker lead that was 
too large to be safely manipulated in the pleural 
space. The patient subsequently recovered well and 
was eventually discharged. In the second case, a 
prototype VATS needle holder was inadequate for 
suturing the parietal pleura in a 17.1 kg patient with 
persistent chylothorax 9 days after VATS vascular 
ring division. A 3 cm left lateral thoracotomy admit- 
ted a standard needle holder, 'and the chylous leak 
was effectively controlled. One additional patient 
required a thoracotomy for persistent chylothorax 
after VATS thoracic duct ligation. The patient was a 
3-year-old child in whom a right chylothorax had 
developed after complete repair of tetralogy of 
Fallot. A VATS thoracic duct ligation was per- 
formed through the right side of the chest. No 
intraoperative problems developed, and the thoracic 
duct and surrounding tissues were ligated at the 
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Table VI. Clinical VA TS results 
Technical 
Procedure n success* 
PDA 
Elective 25/26 96% 
Premature 4/5 80% 
Vascular ing 5/8 63% 
Other procedures 5/9 56% 
Total 39/48 81% 
*Procedure was completed without horacotomy. 
aortic hiatus with vascular clips and intracorporeal 
suture ligation. The chylous drainage persisted after 
the operation, and after 7 more days the patient 
underwent open ligation. At thoracotomy, the 
VATS ligation looked secure, and no leak was 
identified. Mass ligation was performed beneath the 
previous VATS ligation, the drainage ceased, and 
the patient recovered. 
COMPLICATIONS. One premature neonate died of 
multiple organ system failure, 39 days after a VATS 
pericardial window, unrelated to the procedure. 
Follow-up interviews were obtained in eight of the 
nine surviving patients from 10 days to 8 months 
(median 4 months) after the operation. These re- 
vealed symptomatic mprovement in all, with no 
wound infections or chest wall pain. 
Discussion 
We have shown that VATS can be safely applied 
to neonates, infants, and children with diverse con- 
genital cardiovascular lesions. The justification for 
pursuing the VATS approach--to minimize surgical 
trauma--taust be compelling, given the known effi- 
cacy of open techniques. The potential long-term 
morbidity of thoracotomy includes coliosis, breast 
deformity, winged scapula, shoulder weakness, re- 
duced shoulder mobility, and chest wall pain syn- 
dromes. 4"7 A pure VATS technique might reduce 
these sequelae because chest wall muscles are not 
cut, ribs are not retracted, intercostal ligaments are 
not stretched, and incisions are smaller. Short-term 
follow-up observations in adult patients uggest that 
VATS decreases arly postoperative chest wall pain, 
producing less respiratory dysfunction and shorter 
hospital stays, s Chest wall pain is ditticult o quantify 
in neonates and infants; however, we have observed 
rapid return to full activity after VATS procedures, 
leading to short hospitalizations. 
Laboratory experience was essential to develop 
safe instruments and techniques, in the absence of 
prior experience with VATS cardiovascular p oce- 
dures in newborn infants. Size constraints altered 
anesthetic approaches and surgical techniques. In- 
struments from other surgical specialties, including 
orthopedics and otolaryngology, were adapted to 
pediatric cardiothoracic VATS, and several new 
instruments were designed. The total operating 
room times for PDA interruption showed more 
variability in the first half of the experience, as 
the operative team became familiar with the tech- 
nique, whereas procedure times (which more 
accurately reflected the surgeon's practice in the ani- 
mal laboratory) did not vary significantly over the 
course of the clinical experience, while decreasing 
steadily. Experience and improved instruments should 
decrease the likelihood of unplanned conversion to 
thoracotomy, which was 3% for PDA interruption 
(exeluding the planned thoracotomy in the first pa- 
tient) and 44% in the additional procedures, in which 
instruments and techniques were not as well devel- 
oped (Table VI). Conversion to a thoracotomy ne- 
gates much of the advantage of the thoracoscopic 
approach and should be considered a technical failure, 
stimulating efforts to improve technique or instru- 
ments. 
Ironically, PDA, a relatively simple lesion, now 
presents a clinical conundrum, with multiple thera- 
peutic options and no clearly superior approach. 
Concerns about the long-term functional and cos- 
metic effects of thoracotomy are driving the pursuit 
of less traumatic approaches. Minimally invasive 
transcatheter techniques are limited by various ex- 
clusion criteria, based on patient size (5.2F intro- 
ducer sheaths for devices will not fit the femoral 
vessels of infants weighing less than 4 kg) and ductal 
anatomy (coils are not secure in short PDAs or 
those over 2.5 mm in diameter9), which may not be 
apparent until catheterization. The risks of device 
embolization 1° and catheterization lx must also be 
considered, as well as the theoretical risk of arteritis 
in patients with an intravascular foreign body. PDA 
interruption can be effectively performed with 
VATS, 2 with minimal chest wall trauma and rapid 
recovery, without restrictions based on patient size 
or duct anatomy. Experience with VATS PDA 
interruption is too preliminary to determine the risk 
of hemorrhage, reeurrent nerve injury, chylothorax, 
and pulmonary artery distortion. Assessed by Dopp- 
ler echocardiography, themost sensitive and repro- 
ducible standard available, our short-term incidence 
of residual PDA flow (12% at 2 months) compares 
favorably with results with the Rashkind transcath- 
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eter device (38% at 1 year 12) and open surgical 
ligation (23% at 4 months13). VATS may combine 
the reduced trauma of the transcatheter t chniques 
with the efficacy of open surgical igation, without 
introducing complex exclusion criteria. An effective 
VATS procedure should also be included in the 
therapeutic strategy for PDA in premature newborn 
infants, in whom indomethacin therapy, with resid- 
ual patency as high as 21%, 14 holds primacy in the 
absence of a less invasive approach. Given the 
recent controversy regarding the relative cost and 
etficacy of transcatheter devices and open surgical 
techniques 15 and the introduetion of VATS, a pro- 
spective trial would be useful to clarify the appro- 
priate treatment algorithms for PDA. 
VATS vascular ring division can be accomplished 
in patients with the appropriate anatomic substrate. 
Right aortic arch with aberrant left subclavian artery 
and left ligamentum, and double aortic arch with an 
atretic left arch constitute a majority of vascutar 
rings in most series. 16 These rings, and most of the 
rarer forms, can be divided by VATS, with the use of 
techniques similar to those for PDA interruption. 
Until effective ndoscopic vascular clamps are avail- 
able, caution dictates that patent vascular structures 
necessitating division should be approached with at 
least a limited thoracotomy. 
Finally, VATS should be considered in the man- 
agement of complex congenital heart defects. A 
minimally invasive approach may be advantageous 
in patients undergoing staged repair of cyanotic 
heart defects, certainly by decreasing chest wall 
trauma nd possibly by limiting collateral formation. 
Reduced chest wall scarring may also attenuate the 
risks of reoperation i  patients requiring multiple 
staged procedures. With further development, 
VATS could be applied to diaphragm plication, lung 
and heart-lung transplant biopsies, pulmonary ar- 
tery banding, and interruption of anomalous left 
superior vena cava. Further technique and instru- 
ment development should address everal prob- 
lems including prolonged VATS procedure times, 
limited vascular control, and the frequent need to 
convert to thoracotomy. Efforts taust also be 
made to document prospectively that the goals of 
pediatric VATS--reduced pulmonary dysfunc- 
tion, chest wall trauma, pain, hospital stay, and 
cost--are being achieved without compromising 
surgical results. 
We acknowledge Nancy R. Cook, ScD, for her assis- 
tance as our consultant s atistician. 
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Discussion 
Dr. Antonio F. Corno (Milan, Italy). I have a couple of 
questions. First, did you compare the patency rate you 
observed after PDA closure with this technique with the 
other conventional surgical technique or with the inter- 
ventional cardiology approach? Second, did you ever use 
this technique to treat patients with paralysis of the 
diaphragm because of phrenic nerve damage? If not, can 
you use your animal model to study this application? 
Dr. Carl Lewis Backer (Chicago, Ill.). This innovative 
use of VATS techniques may have some promise for 
selected pediatrie patients. For comparison, I thought I
would share with you out experience with open thoracot- 
omy for the diagnosis of PDA. We reeently reviewed our 
results at Children's Memorial Hospital with division and 
oversewing of a PDA and presented this to the American 
Surgical Association. Between 1947 and 1993, 1088 chil- 
dren underwent division and oversewing of a PDA 
through an open thoracotomy. In that group of more than 
1000 patients there was no mortality or significant mor- 
bidity. In the follow-up, for which color Doppler echocar- 
diography and, in some circumstances, cardiac catheter- 
ization for other indications were used, there were no 
recurrences. Twenty patients during the same time period 
had simple ligation, and there was one recurrence in this 
group in a child on whom Dr: Potts operated very early in 
the series. We would maintain that this gold standard of 
no mortality and no recurrence in more than 1000 patients 
having open thoracotomy and oversewing and division 
compares favorably with your 12% recurrence rate. We 
have used a muscle-sparing thoracotomy, limited use of 
chest tubes, and same day admission surgery, so that the 
mean hospital stay is now only 3.8 days. This length of stay 
comes very close to the results with the VATS procedure. 
I have two questions. The first relates to the patient with 
a vascular ring. When a vascular ring is divided, the 
tension on that vessel causes the two stumps to retract. 
Even after oversewing the stumps I am sometimes a little 
nervous, because the stump can retract into the posterior 
mediastinum once the clamp is removed. I wonder if these 
patients with a vascular ring are at increased risk of 
life,threatening hemorrhage with the VATS technique. 
Second, have you evaluated the cost of the VATS 
approach? In the study of the percutaneous transcatheter 
ductus device, there was no question that the device was 
more expensive than an open thoracotomy. With the eost 
of having two assistants, having a longer operating room 
time, and having to use more complex disposable quip- 
ment, I wonder whether the cost is actually going to be 
more than in a standard open thoracotomy even though 
the patient may be going home 1 day earlier. 
Dr. William G. Williams (Toronto, Ontario, Canada). 
We have had one disaster from a PDA clip eroding into 
the bronchus. That may not mean that we should not use 
clips, but it does mean that we should be careful how they 
are positioned. Do you have enough flexibility through a 
scope to position the clip so that it is not protruding 
toward the esophagus or airway? 
If a 6-month-old child with a PDA were admitted to 
your facility, would he or she be sent to the eatheterization 
laboratory or to the operating room to have the PDA 
oceluded. 
At what point do you consider a ductus too large to 
close by your technique? 
Dr. Burke. Perhaps the most sensitive test available to 
assess PDA procedures is Doppler interrogation for re- 
sidual flow. According to that standard, the incidence of 
residual flow after Rashkind device placement is 38% at 1 
year, 23% after open surgical igation, and 12% in our 
VATS experience. 
We have considered the use of VATS for diaphragm 
plication, espeeially in neonates with phrenic nerve injury 
after cardiac operations who cannot be weaned from 
the ventilator. We have devised a technique of suturing 
the dome of the diaphragrn, bringing the suture out the 
anterior chest wall. 
Dr. Backer's group has achieved excellent results after 
PDA division. As our instruments have evolved, our 
incidence of trace residual Doppler flow has decreased, 
but without dividing the ductus, we will have some inci- 
dence of residual flow. Our cardiologists consider an 
audible murmur evidence of significant residual flow, but 
we do not know the clinieal importance of trace Doppler 
flow. 
The motivation to pursue the VATS technique is the 
same force driving the cardiologists to devise transcath- 
eter techniques. We more elosely approximate sound 
surgieal principles with VATS than is possible during 
catheterization. Small incisions for PDA operations do 
not compare with VATS. Attempting PDA division 
through very small incisions compromises visualization 
and maneuverability. VATS instruments readily illumi- 
nate and magnify small spaces and are designed to be 
manipulated in eonfined areas. 
Endoscopic clamps are being developed for VATS 
vaseular ing division. We currently exclude patients who 
require division of patent vascular structures. 
Until mechanical arms are developed to handle instru- 
ments, we need two assistants. Ten of our last 12 PDA 
patients were discharged the day after the operation, so 
we anticipate decreased costs. 
Clip appliers and lung retractors were difficult to design. 
We use an angled clip applier, with three clip sizes. 
Ideally, we will develop effective intracorporeal suturing 
techniques. 
Our cardiologists support he VATS approach, perceiv- 
ing that the patients have less chest wall pain after the 
operation and a low incidence of residual flow. Most 
patients presenting to Children's Hospital with PDA are 
referred for VATS interruption. 
Our largest clip has a diameter of 11 mm. We will not 
attempt VATS on a ductus larger than 1 cm to avoid the 
risk of impaling the duct. 
